Urologists named at Roswell Park, Alabama Urology, Vanderbilt

August 13, 2009

James L. Mohler, MD, has been promoted to senior vice president for translational research at Roswell Park Cancer Institute (RPCI) in Buffalo, NY.

James L. Mohler, MD, has been promoted to senior vice president for translational research at Roswell Park Cancer Institute (RPCI) in Buffalo, NY.

Dr. Mohler joined RPCI in 2003 as chair of the department of urologic oncology and leader of Roswell’s prostate program. He is also professor of urology at the University at Buffalo School of Medicine and Biomedical Sciences. He earned his medical degree from the Medical College of Georgia.

"Dr. Mohler has set a high standard for integrity, superb clinical care, and evidence-based approaches to therapy of urologic cancers and cutting-edge basic and translational research since he joined the Roswell Park faculty in 2003," said RPCI president and CEO Donald L. Trump, MD. "The robust translational research program at Roswell Park will benefit from his expanded executive leadership."

In other recent appointments:

Howard Winfield, MD, has joined West Alabama Urology Associates in Tuscaloosa. He previously was a professor of urology and director of laparoscopic, robotic, and minimally invasive urologic surgery at the University of Iowa Hospitals, Iowa City. A pioneer in the use of the da Vinci surgical platform, Dr. Winfield is the author of numerous papers on urology and minimally invasive surgery, and is reportedly the first person in the world to remove a cancerous portion of a kidney laparoscopically. He earned his medical degree at McGill University.

David Penson, MD, MPH, has been named professor of urologic surgery at Vanderbilt University Medical Center, Nashville, TN, and director of Vanderbilt’s Center for Surgical Quality and Outcomes Research. Dr. Penson was previously associate professor of urology and preventive medicine at the Keck School of Medicine at the University of Southern California, Los Angeles. Upon completing his residency at UCLA, Dr. Penson was awarded both an American Foundation for Urologic Disease Health Policy Research Scholarship and a Robert Wood Johnson Clinical Scholars Fellowship. His research interests include prostate and bladder cancer, female urology, and sexual dysfunction.